Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment
techniques are rapidly expanding the availability of therapeutic options for glaucoma. These …

Alternative drug delivery approaches and novel MIGS devices broaden the treatment
options for patients with glaucoma. This will allow the clinician to customize treatment by …

Glaucoma is one of the world's leading causes of blindness, and its management is
challenging. The main objective is to lower intraocular pressure through medical, para …

The delivery of ophthalmic drugs is challenging despite easy accessibility via the ocular
surface. Topical instillation of eye drops is a relatively easy and most commonly used as a …

Glaucoma is a sight threatening disease process whose major modifiable risk factor is
intraocular pressure (IOP). Although laser and surgical treatments to lower IOP continue to …

Reduction of intraocular pressure (IOP) by pharmaceutical or surgical means has long been
the standard treatment for glaucoma. A number of excellent drugs are available that are …

Introduction: New modalities for providing sustained drug delivery in glaucoma continue to
be developed and aim to improve on the limitations inherent to topical eye drops. This article …

Objective To review the published literature and summarize clinically relevant information
about novel, or emerging, surgical techniques for the treatment of open-angle glaucoma and …

Abstract Purpose of Review In this article, we review new and emerging drug delivery
methods used in the treatment of glaucoma. Recent Findings Several methods for sustained …

Newer medications may be able to extend the duration of medically controlled glaucoma,
delaying or possibly eliminating the need of glaucoma surgery for some patients. Alternative …